CLOSE| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 20, 2024 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 185,100 | -- | 988,804 |
| Feb 15, 2024 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 84,270 | -- | 803,704 |
| Feb 21, 2023 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 85,152 | -- | 839,397 |
| Feb 16, 2023 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 101,911 | -- | 754,245 |
| Feb 22, 2021 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 55,711 | -- | 558,680 |
| Feb 17, 2021 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 136,842 | -- | 502,969 |
| Feb 20, 2020 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,963 | -- | 396,509 |
| Feb 25, 2019 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 33,071 | -- | 306,564 |
| Sep 21, 2018 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 35,324 | -- | 224,758 |
| Jul 31, 2018 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 14,027 | -- | 224,758 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.